These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8863823)

  • 1. Covalent modification of transmembrane span III of the A1 adenosine receptor with an antagonist photoaffinity probe.
    Kennedy AP; Mangum KC; Linden J; Wells JN
    Mol Pharmacol; 1996 Oct; 50(4):789-98. PubMed ID: 8863823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 125I-BW-A844U, an antagonist radioligand with high affinity and selectivity for adenosine A1 receptors, and 125I-azido-BW-A844U, a photoaffinity label.
    Patel A; Craig RH; Daluge SM; Linden J
    Mol Pharmacol; 1988 Jun; 33(6):585-91. PubMed ID: 3380075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization by photoaffinity labeling of natriuretic peptide receptor-A binding domain.
    McNicoll N; Gagnon J; Rondeau JJ; Ong H; De Léan A
    Biochemistry; 1996 Oct; 35(39):12950-6. PubMed ID: 8841141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 125I-2-[4-[2-[2-[(4-azidophenyl)methylcarbonylamino] ethylaminocarbonyl]ethyl]phenyl] ethylamino-5'-N-ethylcarboxamidoadenosine labels transmembrane span V of the A2a adenosine receptor.
    Piersen CE; True CD; Wells JN
    Mol Pharmacol; 1994 May; 45(5):871-7. PubMed ID: 8190104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photoaffinity labeling with UMP of lysine 992 of carbamyl phosphate synthetase from Escherichia coli allows identification of the binding site for the pyrimidine inhibitor.
    Cervera J; Bendala E; Britton HG; Bueso J; Nassif Z; Lusty CJ; Rubio V
    Biochemistry; 1996 Jun; 35(22):7247-55. PubMed ID: 8679554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential docking of high-affinity peptide ligands to type A and B cholecystokinin receptors demonstrated by photoaffinity labeling.
    Dong M; Liu G; Pinon DI; Miller LJ
    Biochemistry; 2005 May; 44(17):6693-700. PubMed ID: 15850403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photolabelling the rat urotensin II/GPR14 receptor identifies a ligand-binding site in the fourth transmembrane domain.
    Boucard AA; Sauvé SS; Guillemette G; Escher E; Leduc R
    Biochem J; 2003 Mar; 370(Pt 3):829-38. PubMed ID: 12495432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De novo analysis of receptor binding affinity data of xanthine adenosine receptor antagonists.
    Dalpiaz A; Gardenghi A; Borea PA
    Arzneimittelforschung; 1995 Mar; 45(3):230-3. PubMed ID: 7741774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irreversible activation of the gonadotropin-releasing hormone receptor by photoaffinity cross-linking: localization of attachment site to Cys residue in N-terminal segment.
    Davidson JS; Assefa D; Pawson A; Davies P; Hapgood J; Becker I; Flanagan C; Roeske R; Millar R
    Biochemistry; 1997 Oct; 36(42):12881-9. PubMed ID: 9335546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning, expression and pharmacological characterization of rabbit adenosine A1 and A3 receptors.
    Hill RJ; Oleynek JJ; Hoth CF; Kiron MA; Weng W; Wester RT; Tracey WR; Knight DR; Buchholz RA; Kennedy SP
    J Pharmacol Exp Ther; 1997 Jan; 280(1):122-8. PubMed ID: 8996189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Site-directed mutagenesis of the human A1 adenosine receptor: influences of acidic and hydroxy residues in the first four transmembrane domains on ligand binding.
    Barbhaiya H; McClain R; Ijzerman A; Rivkees SA
    Mol Pharmacol; 1996 Dec; 50(6):1635-42. PubMed ID: 8967987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reconstitution of bovine A1 adenosine receptors and G proteins in phospholipid vesicles: betagamma-subunit composition influences guanine nucleotide exchange and agonist binding.
    Figler RA; Lindorfer MA; Graber SG; Garrison JC; Linden J
    Biochemistry; 1997 Dec; 36(51):16288-99. PubMed ID: 9405064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation, properties, reactions, and adenosine receptor affinities of sulfophenylxanthine nitrophenyl esters: toward the development of sulfonic acid prodrugs with peroral bioavailability.
    Yan L; Müller CE
    J Med Chem; 2004 Feb; 47(4):1031-43. PubMed ID: 14761205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of the enantiomers of the potent and selective A1-adenosine antagonist 1,3-dipropyl-8-[2-(5,6-epoxynorbonyl)]-xanthine.
    Pfister JR; Belardinelli L; Lee G; Lum RT; Milner P; Stanley WC; Linden J; Baker SP; Schreiner G
    J Med Chem; 1997 Jun; 40(12):1773-8. PubMed ID: 9191953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of specific sites involved in ligand binding by photoaffinity labeling of the receptor for the urokinase-type plasminogen activator. Residues located at equivalent positions in uPAR domains I and III participate in the assembly of a composite ligand-binding site.
    Ploug M
    Biochemistry; 1998 Nov; 37(47):16494-505. PubMed ID: 9843416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agonist photoaffinity labeling of A1 adenosine receptors: persistent activation reveals spare receptors.
    Lohse MJ; Klotz KN; Schwabe U
    Mol Pharmacol; 1986 Oct; 30(4):403-9. PubMed ID: 3020390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipeptide antibodies localize N-(4-azido-3-[125I] iodophenethyl)spiperone binding to the carboxyl-terminal portion of the D2 dopamine receptor.
    David C; Fuchs S
    Mol Pharmacol; 1991 Nov; 40(5):712-6. PubMed ID: 1834930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [(3)H]MRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors.
    Varani K; Merighi S; Gessi S; Klotz KN; Leung E; Baraldi PG; Cacciari B; Romagnoli R; Spalluto G; Borea PA
    Mol Pharmacol; 2000 May; 57(5):968-75. PubMed ID: 10779381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of spin-labeled probes for adenosine receptors.
    Ilas J; Pecar S; Hockemeyer J; Euler H; Kirfel A; Müller CE
    J Med Chem; 2005 Mar; 48(6):2108-14. PubMed ID: 15771453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of a simple behavioral response mediated selectively by central adenosine A1 receptors, using in vivo and in vitro techniques.
    Marston HM; Finlayson K; Maemoto T; Olverman HJ; Akahane A; Sharkey J; Butcher SP
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1023-30. PubMed ID: 9618404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.